Stan Lapidus BSEE
Chairman Board of Directors, Mercy BioAnalytics, Binx Health, Mirvie, Board Member, Lucid Dx, Droplet Biosciences, Sunbird Bio & PathAI
Stan Lapidus is an inventor and entrepreneur who currently serves on a number of healthcare and medical technology boards. He also serves as an advisor to CU Innovations.
He was the founding CEO of three medical diagnostics companies. Two of them have been notably successful.
Cytyc Corp., which he founded in 1987, revolutionized early detection of cervical cancer through its development of the modern Pap test—the ThinPrep. The two ThinPrep prototypes are at the Smithsonian’s American Museum of National History.
EXACT Sciences, which he founded in 1995, pioneered non-invasive early detection of colorectal cancer through its Cologuard test. Since its introduction, Cologuard has become one of the fastest growing tests in the history of the diagnostics industry.
Stan holds 37 patents, primarily in methods for early detection of cancer. He served as an instructor at MIT from 2001 to 2017 focusing on the design, conduct and analysis of clinical trials.
He was elected as a Fellow of the American Institute of Medical and Biological Engineering for his contributions to early cancer detection.
Stan graduated from Cooper Union in New York City with a BS degree in electrical engineering.
PLATINUM SPONSORS:
SPONSORS:
Reservation Policy & Attendance Limit: This event has an attendance limit of 300 people and seats will be reserved on a first-come, first-served basis. Please be sure to register as soon as possible to reserve your seat and ensure your attendance.
*We strive to be inclusive. All are welcome to attend!